BRAIN Biotech AG (ETR:BNN)
2.380
-0.250 (-9.51%)
At close: Mar 27, 2026
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €52 million as of March 27, 2026. Its market cap has decreased by -6.30% in one year.
Market Cap
52.00M
Enterprise Value
46.85M
Revenue
49.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.38
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 52.00M, a decrease of -65.18%. That is a compound annual growth rate of -9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 52.00M | -5.56% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evonik Industries AG | 7.66B |
| Fuchs SE | 4.26B |
| Wacker Chemie AG | 4.00B |
| Verbio SE | 2.78B |
| AlzChem Group AG | 1.64B |
| LANXESS Aktiengesellschaft | 1.52B |
| Uzin Utz SE | 355.62M |
| H&R GmbH & Co. KGaA | 149.63M |